Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2005-11-22
2005-11-22
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
Reexamination Certificate
active
06967193
ABSTRACT:
Novel purine compounds of the Formula 1, pharmacuetically acceptable prodrugs and salts thereof, and their use as fructose 1,6-bisphosphatase inhibitors
REFERENCES:
patent: 3931206 (1976-01-01), Bowler et al.
patent: 4000305 (1976-12-01), Bowler et al.
patent: 4278791 (1981-07-01), Botta et al.
patent: 4939130 (1990-07-01), Jaeggi et al.
patent: 4968790 (1990-11-01), DeVries et al.
patent: 5021443 (1991-06-01), Bru-Magniez et al.
patent: 5124319 (1992-06-01), Baudy et al.
patent: 5294608 (1994-03-01), Lang et al.
patent: 5376665 (1994-12-01), Miyata et al.
patent: 5395826 (1995-03-01), Naumann et al.
patent: 5414088 (1995-05-01), Von Der Saal et al.
patent: 5480874 (1996-01-01), Shoji et al.
patent: 5498617 (1996-03-01), Naumann et al.
patent: 5519138 (1996-05-01), Ries et al.
patent: 5658889 (1997-08-01), Gruber et al.
patent: 5661174 (1997-08-01), Naumann et al.
patent: 5958904 (1999-09-01), Cordi et al.
patent: 5985856 (1999-11-01), Stella et al.
patent: 6054587 (2000-04-01), Reddy et al.
patent: 6110903 (2000-08-01), Kasibhatla et al.
patent: 6284748 (2001-09-01), Dang et al.
patent: 6294672 (2001-09-01), Reddy et al.
patent: 6312662 (2001-11-01), Erion et al.
patent: 6399782 (2002-06-01), Kasibhatla et al.
patent: 6489476 (2002-12-01), Dang et al.
patent: 1324383 (1993-11-01), None
patent: 28 55 659 (1980-07-01), None
patent: 0 012 909 (1980-07-01), None
patent: 0 73 525 (1983-03-01), None
patent: 0 117 429 (1984-09-01), None
patent: 0 354 322 (1990-02-01), None
patent: 0 354 806 (1990-02-01), None
patent: 0 427 799 (1991-05-01), None
patent: 0 449 196 (1991-10-01), None
patent: 0 604 657 (1994-07-01), None
patent: 0 620 227 (1994-10-01), None
patent: 0 632 048 (1995-01-01), None
patent: 0 753 525 (1997-01-01), None
patent: 05-097883 (1993-04-01), None
patent: WO 92/13864 (1992-08-01), None
patent: WO 94/07867 (1994-04-01), None
patent: WO 94/20508 (1994-09-01), None
patent: WO 94/22864 (1994-10-01), None
patent: WO 96/21644 (1996-07-01), None
Curran et al., “Thermolysis of Bis[2-[(trimethysilyl)oxy]prop-2-yl]furoxan (TOP-furoxan). The First Practical Method for Intermolecular Cycloaddition of an in Situ Generated Nitrile Oxide with 1,2-Di-and Trisubstituted Olefins,”J. Am. Chem. Soc., 107:6023-6028 (1985).
Fresenius, “Organic Chemical Nomenclature” (E. Horwood, Ltd, Chichester) p. 29 & 1st index page, 1989.
Hawley, “Condensed Chemical Dictionary”, 9th Ed. (Van Norstrand Reinhold Co. NY) p. 25, 1977.
Garuti et al., “Synthesis and Biological Evaluation of Some New Phosphates,” Pharmazie, 47:295-297 (1992).
Grant, “Grant and Hack's Chemical Dictionary” (McGraw Hill, NY) p. 22, 1987.
Maryanoff et ., “Stereoselective Synthesis and Biological Activity of β- and α-D- Arabinose 1,5-Diphosphate: Analogues of a Potent Metabolic Regulator,”J. Med. Chem.106:7851-7853.
Yoshino et al., “Organic Phosphorus Compounds. 2. Synthesis and Coronary Vasodilator Activity of (Benzothiazolylbenzyl) Phosphonate Derivatives,”J. Med. Chem.32:1528-1532 (1989).
Dang Qun
Erion Mark D.
Kasibhatla Srinivas Rao
Reddy K. Raja
Reddy M. Rami
Berch Mark L.
Metabasis Therapeutics, Inc.
Paul Hastings Janofsky & Walker LLP
LandOfFree
Purine inhibitors of fructose-1,6-bisphosphatase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purine inhibitors of fructose-1,6-bisphosphatase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine inhibitors of fructose-1,6-bisphosphatase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3457804